Clinical Trial Update: Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating regimens based on Tuvonralimab and Iparomlimab for the neoadjuvant treatment of biliary tract cancer; recruitment is on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Biliary Tract Cancer | Phase 2 | Status: RECRUITING